• PNS22 Hospital Ownership and National Essential Medicines Policy: A Comparative Study between the Public and Private Primary Health-Care Institutions in Nantong, China

    Sep 1, 2020, 00:00

  • PCN57 Frequency of Myalgia in Patients Receiving Platinum Chemotherapy

    Sep 1, 2020, 00:00

  • PRO13 In-Silico Determination of Therapeutic Possibilities for Type-1 Gaucher Disease: A GENE Database Linked Analysis

    Sep 1, 2020, 00:00

  • PCN52 Disease Burden of Prostate Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN29 Evaluation of Healthcare Workers' Knowledge, Attitude and Practices Related to Covid-19: A Multicenter CROSS-Sectional Study from Pakistan

    Sep 1, 2020, 00:00

  • PCN92 An Investigation of Estimation Efficiency of Area UNDER the Curve (AUC) Using Parametric Models

    Sep 1, 2020, 00:00

  • PCN48 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Neoadjuvant Treatment of HER2-Positive EARLY or Locally Advanced Breast Cancer: Update Results after National ...

    Sep 1, 2020, 00:00

  • PNS14 Investigation of Physicians’ Digital Activities on Mitigating the IMPACT of Covid-19 in China

    Sep 1, 2020, 00:00

  • PND29 Children with Hyperactive-Impulsive Disorder Benefit from Yoga Exercises

    Sep 1, 2020, 00:00

  • Disclosure Information

    Sep 1, 2020, 00:00

  • PNS70 EQ-5D-5L in China and JAPAN: Population Norms and Comparison between the Countries

    Sep 1, 2020, 00:00

  • PMU1 Dancing with the Dragon: Considerations and Learnings in the 2019 China National Reimbursement Drug LIST Negotiations

    Sep 1, 2020, 00:00

  • PND18 The Impact Of Anxiety Caused By Pharmacy Licence Examination Core Competency Of Fourth Year Pharmacy Students Of Burapha University 2018

    Sep 1, 2020, 00:00

  • PIN31 The Epidemiology and Cost of Dengue Disease in Thailand: A Systematic Literature Review

    Sep 1, 2020, 00:00

  • PCV20 A Real-World Study of Patient Characteristics and Treatment Patterns for Atrial Fibrillation in China

    Sep 1, 2020, 00:00

  • PMU11 Current Status of the Use of Prescription Opioids in Korean Elderly Patients: An Analysis of the Health Insurance Review and Assessment Service-Aged Patient Sample DATA

    Sep 1, 2020, 00:00

  • PNS72 Patients Are Playing an Increasing Role in Medical Decisions Due to the Digital Transformation of Healthcare in China

    Sep 1, 2020, 00:00

  • PCV6 MODEL-Based Evaluation on Annual Economic Burden of Coronary Atherosclerotic Heart Disease in China

    Sep 1, 2020, 00:00

  • PCN80 Comparison of Treatment Among Chronic Myeloid Leukemia Patients in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PMS14 CHILD with Cerebral Palsy Benefited from Motor Sequencing Training: Case Report

    Sep 1, 2020, 00:00

  • PGI7 Cost-Effectiveness Analysis of Vonoprazan Versus Proton Pump Inhibitors in the Treatment of Reflux Esophagitis in China

    Sep 1, 2020, 00:00

  • Table of Contents

    Sep 1, 2020, 00:00

  • PCN38 Cost-Effectiveness of Mammography As a Screening Test for EARLY Detection of Breast Cancer

    Sep 1, 2020, 00:00

  • PIN45 Comparison of Antibiotics Policies between European Union Countries and JAPAN

    Sep 1, 2020, 00:00

  • PCN54 Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    Sep 1, 2020, 00:00

  • PNS34 IMPACT of Drug Price Formation Mechanism on Medicine Availability: Evidence from China

    Sep 1, 2020, 00:00

  • PND5 Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in the United States

    Sep 1, 2020, 00:00

  • PMU25 Measuring Medication Adheren Application of Group-Based Trajectory MODEL for Australians with Chronic Health Conditions Requiring Continuous Use of Medication

    Sep 1, 2020, 00:00

  • PCN99 What Is the IMPACT of Chemotherapy Induced Peripheral Neuropathy on Individuals and the Community?

    Sep 1, 2020, 00:00

  • PDG24 Private Primary Care Health Clinics in Malaysia and Uncontrolled Drug Pricing: Employer Health Insurance Coverage for Sustainable Reimbursement Drug Policy

    Sep 1, 2020, 00:00

  • PCN10 ORAL H2RA for Taxane Hypersensitivity Prevention: A Pharmacokinetic-Guided Decision

    Sep 1, 2020, 00:00

  • PMH4 The Psychological and Behavioral Responses to Covid-19 Epidemic in Pregnant Women in China: A Nationwide Survey

    Sep 1, 2020, 00:00

  • PSU14 Patient-Related Risk Factors for Periprosthetic Joint Infection and Postoperative Mortality Following TOTAL Knee Arthroplasty, a Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PDB7 Cost-Effectiveness Analysis of Once-Weekly Semaglutide As the Second-LINE Treatment for Type 2 Diabetes Mellitus Patients

    Sep 1, 2020, 00:00

  • PCV19 Economic Burden of Disease on Patients with ACUTE Myocardial Infarction Combining Dyslipidemia in China

    Sep 1, 2020, 00:00

  • PIN30 Elements to Consider for a Comprehensive Assessment of the Public Health IMPACT of Vaccination

    Sep 1, 2020, 00:00

  • PCN37 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in France

    Sep 1, 2020, 00:00

  • PIH15 NOVEL Target Identification and Drug Repurposing for Systemic Onset Juvenile Idiopathic Arthritis (SJIA): An Insilico Approach

    Sep 1, 2020, 00:00

  • PNS25 Applying Regulatory Science to Traditional Medicines for Improving Public Safety and Facilitating Innovation: Experiences in China

    Sep 1, 2020, 00:00

  • PMS18 Factors Influencing Length of STAY (LOS) and Real-World Discharge Readiness (DR) for TOTAL Knee Arthroplasty in Australia

    Sep 1, 2020, 00:00

  • PRS6 Economic Eligibility Assessment for Patient Assistance Program (PAP) Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Urban China

    Sep 1, 2020, 00:00

  • PMD6 How to Promote the Application of Regulatory Science in Combination Products

    Sep 1, 2020, 00:00

  • PNS45 Research On Comprehensive Evaluation Index System Of Economic Operation Of Public Hospitals In China

    Sep 1, 2020, 00:00

  • PIH19 Inequality of Access to Minimally Invasive Hysterectomy for Patients with Endometrial Cancer in South Korea

    Sep 1, 2020, 00:00

  • PCV32 Clinical Utilization of Antiplatelets and Anticoagulants in ACUTE Coronary Syndrome Patients - a Single-Centered Observational Study in Hong Kong

    Sep 1, 2020, 00:00

  • PCN16 Treatment Cost in Patients with Relapsed Refractory Multiple Myeloma in JAPAN

    Sep 1, 2020, 00:00

  • PMU4 Budget IMPACT Analysis of FLOW Cytometry Application in EARLY Diagnosing of Patients with Primary Immunodeficiency Diseases in China

    Sep 1, 2020, 00:00

  • PNS37 Evalutaion of Time to Reimbursement for Rsa Drugs in Korea

    Sep 1, 2020, 00:00

  • PCN34 The Societal IMPACT of Obinutuzumab in the First-LINE Treatment of Follicular Lymphoma in China

    Sep 1, 2020, 00:00

  • PRS4 Modeling Economic and Health Burden of Chronic Obstructive Pulmonary Disease (COPD) in China over the Next 20 YEARS

    Sep 1, 2020, 00:00

  • PCV24 Health Technology Assessment Submissions for Cardiovascular Interventions in the ASIA-Pacific Region

    Sep 1, 2020, 00:00

  • PMU9 Brand-Switching Behavior Following the Implementation of a 63% Tax Increase on Cigarettes in Taiwan

    Sep 1, 2020, 00:00

  • PRS15 Evaluating Disease and Economic Burden of Severe Asthma in India

    Sep 1, 2020, 00:00

  • PIH1 Development and Validation of a Prediction MODEL on Severe Maternal Outcomes Among Pregnant Women with PRE-Eclampsia: A 10-Year Cohort Study

    Sep 1, 2020, 00:00

  • PND23 Treatment Gaps in Deep Brain Stimulation for Patients with Parkinson's Disease: A Comparative Analysis of Nine High-Income Countries

    Sep 1, 2020, 00:00

  • PNS6 Risk Of Bias In Model-Based Economic Evaluations Of Tobacco Control Interventions In Asia: A Systematic Review

    Sep 1, 2020, 00:00

  • PND13 Burden of Illness of Spinal Muscular Atrophy: An Update

    Sep 1, 2020, 00:00

  • PCN76 Analysis of the Status of the MULTI-Indications for Anticancer Drugs and Their Price Reduction in South Korea

    Sep 1, 2020, 00:00

  • PIN53 The Usability Testing of the Integrated E-Healthcare Services (IEHS) Web-Based Application in the Therapy Management of HIV and Tuberculosis in Indonesia

    Sep 1, 2020, 00:00

  • PCN59 A Systematic Review of Prognostic Factor That IMPACT on Overall Survival and Proression-Free Survival in Triple-Negative Breast Cancer (TNBC)

    Sep 1, 2020, 00:00

  • PIN33 Public Health Behaviour Changes during the Covid-19 Outbreak in China: A Comparison in Different Risk Groups

    Sep 1, 2020, 00:00

  • PRS5 An Environment IMPACT Analysis of the Use of Respimat RE-Usable for the Treatment of Chronic-Obstructive Pulmonary Disorder (COPD) in South-EAST ASIA and South Korea

    Sep 1, 2020, 00:00

  • PNS13 Assessment of Satisfaction with New Competencies and Roles of Nurses in the Framework of Nursing Reform in Kazakhstan

    Sep 1, 2020, 00:00

  • PNS68 Valuating the CHILD Health Utility 9-Dimention in JAPAN: Results from a Nation-Wide School-Based Survey

    Sep 1, 2020, 00:00

  • PBI4 The ISSUE of Patient CO-Pay and Biosimilars in JPN: Is IT Really an ISSUE?

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PCN93 A Comparison of Machine Learning (ML) Algorithms Performance Against Medical Professionals in Diagnosing LUNG Cancer: A Targeted Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN105 Investigating Medical Utilization in Ductal Carcinoma in Situ (DCIS) Women: A Real-World Data Analysis

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PGI4 Projecting the Health Impact of Vaccination with Rotateq in China

    Sep 1, 2020, 00:00

  • PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran

    Sep 1, 2020, 00:00

  • PCN86 Predicting the Unknown - How Health Technology Assessment Agencies Deal with Uncertainty, and the IMPACT This HAS on Patient Access for Immuno-Oncology Therapies

    Sep 1, 2020, 00:00

  • PCN24 Budget IMPACT Analysis (BIA) of Introducing Tisagenlecleucel for the Treatment of Patients with Relapsed and Refractory Diffuse Large B-CELL Lymphoma (R/R DLBCL) in Singapore (SG)

    Sep 1, 2020, 00:00

  • PMS4 Epidemiology, Treatment Patterns, and Economic Burden of Postmenopausal Osteoporosis and Associated Fractures in China in 2017

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PCN53 Cost-Utility Analysis of Dacomitinib As First-LINE Treatment for Patients with Locally Advanced or Metastatic NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PCN13 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus S-1 PLUS Gemcitabine in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN62 Investigation of Diseases Incidence after Administration of Immune Check Inhibitors in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PND27 Valuing Health States Using Discrete Choice Experiment: Case of Cerebral Palsy

    Sep 1, 2020, 00:00

  • PNS56 Effect of the Recall Period for Estimating Inpatient out-of-Pocket Expenditures: Validation Study in Vietnam

    Sep 1, 2020, 00:00

  • PNS67 The Humanistic Burden of Caregiving in China, Japan, and the US

    Sep 1, 2020, 00:00

  • PND28 Children with Hypoxic-Ischaemic Encephalopathy Have a Delay in the Development of Executive Abilities

    Sep 1, 2020, 00:00

  • PCN7 Adverse Events (AES) of Advanced Renal CELL Carcinoma (RCC) Patients Treated with Targeted Therapies in Real World Setting in Korea

    Sep 1, 2020, 00:00

  • PCN25 Hospital Costs Associated with Powered and Manual Staplers in VIDEO-Assisted Thoracic Surgery Lobectomy for LUNG Cancer in a Chinese Teritary Care Hospital

    Sep 1, 2020, 00:00

  • PIN40 Influenza Vaccination in Adult Patients with Hypertension or Diabetes in South Korea: A CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PRS9 Economic Burden of Adult Patients with Asthma Using a CROSS-Sectional Analysis of Survey DATA in ASIA and the U.S

    Sep 1, 2020, 00:00

  • PIN26 Assessment Of Influence Of Education To Parents Towards Completion Of Vaccination : A Randomised Controlled Study

    Sep 1, 2020, 00:00

  • PIN35 Evaluation of Effectiveness of Knowledge Transfer of Antimicrobial Resistance to Hong Kong Elderly: A Quasi-Experiment

    Sep 1, 2020, 00:00

  • PGI2 Quantitative Evaluation to Efficacy and Safety of Biosimilar of Infliximab in Inflammatory Bowel Diseases: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PND19 Economic and Social Factors Affecting Healthcare Expenditure for Households with Cerebrovascular Diseases

    Sep 1, 2020, 00:00

  • PNS29 IMPACT of Pharmacoeconomic Evaluation Guidelines: A Systematic Review of Reporting Quality of Pharmacoeconomic Evaluations for NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PIN8 Analysis of Potential Cost-Savings after Introduction of 0.1% Polihexanide/Betaine Solution for Chronic Wounds in Reimbursement Healthcare System of Korea

    Sep 1, 2020, 00:00

  • PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Databas ...

    Sep 1, 2020, 00:00

  • PMU14 China's 2019 National Reimbursement Drug LIST Update: Implications on Global and Local Manufacturer Strategy

    Sep 1, 2020, 00:00

  • PCV23 Budget IMPACT Analysis of Sacubitril Valsartan for Heart Failure Treatment in Indonesia

    Sep 1, 2020, 00:00

  • PDB3 SGLT2 Inhibitors and Risk of Diabetic Ketoacidosis in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PAM5 Cost-Effectiveness Analysis of Lusutrombopag for the Treatment of Thrombocytopenia in Chronic LIVER Disease Patients PRIOR to an Elective Invasive Procedure in JAPAN

    Sep 1, 2020, 00:00

  • PIN23 Systematic Review of Economic Evaluations of Pneumococcal Conjugate Vaccines in Mainland China

    Sep 1, 2020, 00:00

  • PRS12 Prospective Association between LUNG Function and the Incidence of Diabetes, Asthma, Myocardial Infarction, Hypertension and ALL-Cause Mortality: Competing Risks MODEL

    Sep 1, 2020, 00:00

  • PNS71 ACCESSING MULTIPLE PATIENT DATA SOURCES TO ENHANCE GENERATION OF REAL-WORLD EVIDENCE, OUTCOME RESEARCH AND NON-RESEARCH EVALUATIONS

    Sep 1, 2020, 00:00

  • PDG6 A Cost/Cost-Utility Analysis of Cefaclor Hypersensitivity in South Korea

    Sep 1, 2020, 00:00

  • PIN32 Disease Burden of Hepatitis C Infection Among the General Population in ASIA: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS21 Drug Pricing System Reform and the Formal Introduction of Health Technology Assessment in JAPAN

    Sep 1, 2020, 00:00

  • PCV21 Association between Low-Income Status and Death in Japanese Patients with Heart Failure: Life Study

    Sep 1, 2020, 00:00

  • PCN65 Disease and Economic Burden of Cancer Associated Thrombosis Among SOLID Tumour Malignancy in Malaysia

    Sep 1, 2020, 00:00

  • PIN17 A Systematic Literature Review of the Disease and Economic Burden of Multidrug Resistance Gram Negative Infections (MRGN) in JAPAN

    Sep 1, 2020, 00:00

  • PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

    Sep 1, 2020, 00:00

  • PDG18 Availability, Cost and Affordability of Selected Antibiotics and Antiviral Medicines Against Infectious Diseases from 2013 to 2019 in Nanjing, China

    Sep 1, 2020, 00:00

  • PNS51 The Role of Patients in Health Technology Assessment Process - Experience of Taiwan

    Sep 1, 2020, 00:00

  • PIN5 Evaluating Treatments and Corresponding Mortality Rates in Patients with Acinetobacter Baumannii Infections

    Sep 1, 2020, 00:00

  • PND26 Biological Activity of Ascaridole through Interference of Binding Sites of Topoisomerase I, Topoisomerase II, Acetylcholinesterase, SOD and Catalase for the Treatment of Alzheimer's Disorders

    Sep 1, 2020, 00:00

  • PDB12 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PNS64 Landscape Analysis of Studies in Asia Eliciting Patient Preferences for Therapeutic Interventions

    Sep 1, 2020, 00:00

  • PNS31 Increased Cigarette Taxes and Quitting Behavior Among Adults

    Sep 1, 2020, 00:00

  • PMS17 Usability Testing of a Patient Engagement Digital Platform for TOTAL Knee Arthroplasty (TKA) Patients in JAPAN

    Sep 1, 2020, 00:00

  • PIN18 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in New Zealand

    Sep 1, 2020, 00:00

  • PND14 Identifying Patients with RARE Refractory Epilepsies in Japanese Health Databases: Feasibility for a Burden of Illness Study

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PDG25 Drug Therapy Problem and Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PNS24 Willingness-to-Pay Thresholds Applied for Health Economic Analyses in Oncology in China: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PBI3 The Economic Evaluation Of Clopidogrel In Antiplatelet Therapy Guided By CYP2C19 Gene Polymorphism In The Treatment Of Patients With Coronary Heart Disease

    Sep 1, 2020, 00:00

  • PCN71 Comparing the International Price of Anticancer Drugs and Improving Their Accessibility in South Korea

    Sep 1, 2020, 00:00

  • PNS10 Economic Evaluation in the Philippines before the Era of Mandatory Health Technology Assessment: A Systematic Review

    Sep 1, 2020, 00:00

  • PCN4 Aromatase Inhibitors and Bisphosphonate Use in Postmenopausal Women with Hormone-Receptor Positive Breast Cancer in Hong Kong

    Sep 1, 2020, 00:00

  • PNS40 The Implementation of Volume-Based Drug Procurement Policy in China

    Sep 1, 2020, 00:00

  • PRO8 Analysis of Health Authorities Collaboration for Orphan Drug Designation and Their IMPACT on the Growth of Orphan Drug Market

    Sep 1, 2020, 00:00

  • Prioritization of Medicine Importation by the Private Sector in Sudan: Evidence from a Data Analysis, 2012-2015

    Sep 1, 2020, 00:00

  • PSU12 Landscape Analysis of Analgesics Utilization during Perioperative Period in China

    Sep 1, 2020, 00:00

  • PND21 BUDGET IMPACT OF ROTIGOTINE ON CHINESE NATIONAL MEDICAL FUND PAYMENT FOR PARKINSON'S DISEASE

    Sep 1, 2020, 00:00

  • PUK7 Budget Impact Of A New Mobile Application Reimbursement Strategy For Diabetic Patients In Andhra Pradesh (India)

    Sep 1, 2020, 00:00

  • PND10 Assessing the Cost of Treatment for Myasthenia Gravis Crisis Patients in Australia

    Sep 1, 2020, 00:00

  • PAM2 Cost-Effectiveness of Thread Embedding Therapyfor Patients with Chronic, Herniated Lumbar Disk

    Sep 1, 2020, 00:00

  • PDB15 Cost-Effectiveness of Gliclazide MR-Based Intensive Glucose Control Versus Standard Glucose Control in Type 2 Diabetes Mellitus: Pharmacoeconomic Analysis in Thailand Based on the Advance Trial MODEL

    Sep 1, 2020, 00:00

  • PCN3 Knowledge of Treatment Assignment and Clinician Adverse Event Reporting: An Evaluation in Multiple Myeloma

    Sep 1, 2020, 00:00

  • PIH6 Economic Evaluation of the Automated Resuscitator Device for Asphyxiated Neonates in Tertiary LEVEL Healthcare Setting in India

    Sep 1, 2020, 00:00

  • PMD12 Key Considerations of VALUE Assessment Frameworks for Medical Devices and Diagnostics in ASIA Pacific

    Sep 1, 2020, 00:00

  • PUK2 Assessing Mortality Risk and Renal Outcomes in Chronic Kidney Disease Patients Treated with Sglt-2 Inhibitors or DPP-4 Inhibitors: A Real-World Study

    Sep 1, 2020, 00:00

  • PNS36 Cost-Benefit Analysis of Dental Prevention Programs for Children in Taiwan

    Sep 1, 2020, 00:00

  • PND25 Identification of NOVEL Drug Targets and Exploring Drug Repurposing Avenues for Amyotrophic Lateral Sclerosis

    Sep 1, 2020, 00:00

  • PND3 Patient-Reported Outcomes Following Neuromanual Therapy For Carpal Tunnel Syndrome- Comparison Of Four Patient Healthcare Outcome Measures In A Randomized Clinical Trial

    Sep 1, 2020, 00:00

  • PNS54 Competencies Required in the Profile of the Health Professional for Management and Assistance in Telemedicine Programs: A Review of the Literature

    Sep 1, 2020, 00:00

  • PMS9 Expected Benefits over the Next 20 Years of Osteoporotic Secondary Fracture Prevention Policies Amongst Women in Thailand

    Sep 1, 2020, 00:00

  • PNS28 Recent Japanese Generic Drug Policy and Future Directions

    Sep 1, 2020, 00:00

  • PMU16 Assessing Health Technologies in EARLY Detection of Primary Immunodeficiency Diseases: A Case Study of Evidence-Based VALUE Framework in RARE Diseases

    Sep 1, 2020, 00:00

  • PCN56 Addressing the Credibility GAP of Real-World Evidence Generation in Southeast ASIA: An Analysis of 200 Articles over 10 YEARS

    Sep 1, 2020, 00:00

  • PMU15 Utilization and Spending of Low-VALUE Healthcare UNDER a National Health Insurance Program: A Nationwide Population-Based Study

    Sep 1, 2020, 00:00

  • PIN4 Associations between Thromboprophylaxis and Ventilator-Associated Events Among Patients Receiving Mechanically Ventilated

    Sep 1, 2020, 00:00

  • PMS8 Estimating the Future Clinical and Economic Benefits of Improving Osteoporosis Diagnosis and Treatment Rates Among Women in South Korea: A Simulation Projection Model from 2020-2040

    Sep 1, 2020, 00:00

  • PDG1 Prevalence and Determinants of Serious Spontaneously Reported Adverse Drug Events Among Three Outpatient Care Settings in Ghana: Findings and Implications

    Sep 1, 2020, 00:00

  • PUK3 Cost Consequence Analysis of Remote Monitoring with the Homechoice Claria® with Sharesource® Platform for Automated Peritoneal Dialysis Patients in the Australian Setting

    Sep 1, 2020, 00:00

  • PDB1 Telemedicine Use for Gestational Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

    Sep 1, 2020, 00:00

  • PNS43 Economic Evaluation of a Community-Based Maternal and CHILD Health Service in JAPAN

    Sep 1, 2020, 00:00

  • PRO1 The Market Access Landscape for Orphan Drugs in APAC: A Comparison of Policies in FIVE Major Markets

    Sep 1, 2020, 00:00

  • PIH4 Preoperative Skin Preparation for Caesarean Deliveries in Australian Public Hospitals: Surgical Site Infecton and Cost Outcomes Associated with Using Alcoholic Chlorhexidine Gluconate Applicator Versus Bulk Aqueous Povidone Iodine Solu ...

    Sep 1, 2020, 00:00

  • PCN75 Characterization of Oncology Managed Entry Agreements (MEA) in APAC and Assessment of Payer Considerations

    Sep 1, 2020, 00:00

  • PRS2 Impact Of Knowledge And Attitude On Antibiotic Used For Upperrespiratory Tract Infections At Burapha University 2019

    Sep 1, 2020, 00:00

  • PCN35 Out-of-Pocket Cost of Cancer Treatement: A Systematic Review for Literatures from Taiwan

    Sep 1, 2020, 00:00

  • PMH11 Post Partum Depression:Prevalence, Risk Factors/Causes, Knowledge and Medication Use

    Sep 1, 2020, 00:00

  • PMD8 Mortality after Use of paclitaxel-Based Devices in Peripheral Arteries : A Real-World Analysis

    Sep 1, 2020, 00:00

  • PRO9 Orphan Drug Pricing in JAPAN Since Reform

    Sep 1, 2020, 00:00

  • PCN14 Disease Burden of Waldenstrom's Macroglobulinemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMU24 Using the Medication Adherence Reasons Scale (MAR-SCALE) to Identify the Reasons for Medication NON-Adherence Among Type 2 Diabetes, Migraine, and Depression Medication Users in JAPAN

    Sep 1, 2020, 00:00

  • PUK6 Assessing Trend In Medical Expenditure And Measuring The Impact Of Health-Related Quality Of Life (HRQOL) On Medical Expenditure For U.S. Adults With Diabetes Associated Chronic Kidney Disease (CKD)Using 2002-2016 Medical Expenditure P ...

    Sep 1, 2020, 00:00

  • PDB14 Cost-Effectiveness of Liraglutide Versus Exenatide, BOTH in Combination with Metformin for Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PNS32 Impoverishing Effects Of Out-Of-Pocket Health Expenditures In India

    Sep 1, 2020, 00:00

  • PMH12 Trends in Use of Prescription, over the Counter, and Traditional Chinese Medicine for Mental Health Conditions in China, 2009 - 2017

    Sep 1, 2020, 00:00

  • PSS3 Bioinformatics Analysis of Potential Targets for Drug Repurposing in Contact Eczema through Microarray Profiles

    Sep 1, 2020, 00:00

  • PDG8 The Cost-Effectiveness of Direct-Acting Antivirals Coverage Policies for Patients with Hepatitis C VIRUS Infection in Taiwan

    Sep 1, 2020, 00:00

  • PCN47 Disease Burden of Gastric Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN21 Cost-Effectiveness of Ceftazidime-Avibactam for Gram-Negative Infections with Limited Treatment Options in China

    Sep 1, 2020, 00:00

  • PNS5 Comparison of Instruments Valuing Health-Related Productivity Losses

    Sep 1, 2020, 00:00

  • PIH16 Use of Tripod Checklist to Evaluate the Reporting Quality of Prognostic Prediction Models for Obstetric Care

    Sep 1, 2020, 00:00

  • PCN42 A Real World Comparison of Utility Values Derived from a Discrete Choice Experiment Versus Patient Reported Outcomes in Clinical Trials

    Sep 1, 2020, 00:00

  • PIN7 The Cost Effectiveness Analysis of a Nonavalent Vaccine in China

    Sep 1, 2020, 00:00

  • PCN2 The Effect of IMAGE-Guided Radiotherapy on Cancer Patients' Survival

    Sep 1, 2020, 00:00

  • PSU15 A Cost Analysis of OPEN, Laparoscopic and ROBOT-Assisted Hysterectomy for Endometrial Cancer in Korea

    Sep 1, 2020, 00:00

  • PRS8 The Cost Effectiveness Analysis of SIX COPD Treatment Strategies in China

    Sep 1, 2020, 00:00

  • Valuing Health State: An EQ-5D-5L Value Set for Ethiopians [Editor's Choice]

    Sep 1, 2020, 00:00

  • PDB22 Drug Related Problems in Type-2-Diabetes Mellitus with and without Cardiovascular Diseases: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIH9 Quantification Of Sleep Quality Among Older Adults In The State Of Penang, Malaysia

    Sep 1, 2020, 00:00

  • PNS7 A Systematic Review of Cost Utility Studies Conducted from an Indian Perspective

    Sep 1, 2020, 00:00

  • PRO14 Quality of Life in Patients with Gaucher Disease and Factors Associated: A Study on Adult Patients in China

    Sep 1, 2020, 00:00

  • PIN19 Direct Medical Cost of HIV/AIDS Treatment in Vietnam

    Sep 1, 2020, 00:00

  • PCN70 Budget Savings from Patent Expiration of Cancer Drugs in South Korea

    Sep 1, 2020, 00:00

  • PRS13 Market Access of Asthma and COPD Medications As a Tool to Increase Drugs Availability in Russian Federation

    Sep 1, 2020, 00:00

  • PCN41 Cost-Effectiveness of Pembrolizumab in Combination with Chemotherapy in the 1ST LINE Treatment of Metastatic NSCLC in Taiwan

    Sep 1, 2020, 00:00

  • PMD5 Evaluation of Cost Analysis of the Midline Catheter Versus Peripherally Inserted Central Catheter in Korea in the Inpatient Setting

    Sep 1, 2020, 00:00

  • PND9 Effects and Cost of Gastrodin Injection on Dizziness and Vertigo: A Propensity Score-Matched Cohort Study Based on Real-World DATA

    Sep 1, 2020, 00:00

  • PRO12 Investigation of Consistency of Haemophilia a Care in JAPAN: A Claims-Based Cohort Study

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PRO16 Healthcare Resource Utilization (HCRU) in Patients with Generalized Pustular Psoriasis (GPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PCN11 The Challenges and Unmet Needs in the Management of Hepatocellular Carcinoma (HCC) Patients and Burden of Advanced HCC across Hong Kong, Singapore and Thailand

    Sep 1, 2020, 00:00

  • PMD13 Estimating the Cost of Treating Myasthenia Gravis Patient in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PDB26 Knowledge, Attitude and Practices of Insulin Self-Administration Techniques Among Diabetic Patients

    Sep 1, 2020, 00:00

  • PCN8 Real World Treatment Patterns, Healthcare Resource Utilization (HCRU), Economic Outcomes and Survival Associated with Esophageal Cancer in JAPAN

    Sep 1, 2020, 00:00

  • PSS4 Disease Burden of Rvo-ME in China – a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PIN16 Disease Burden of Progressive Chronic Hepatitis B in China

    Sep 1, 2020, 00:00

  • Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
  • »